Navigation Links
Access Pharmaceuticals to Present New Data on ProLindac(TM) at the AACR Annual Meeting 2008 Conference
Date:4/10/2008

DALLAS, April 10 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that its collaborators at prestigious institutes in France and Italy will be presenting new preclinical data on its lead anticancer compound, ProLindac(TM), at the American Association for Cancer Research (AACR) Annual Meeting 2008 taking place April 12-16, 2008 at the San Diego Convention Center. The poster presentation entitled "Characterization of predictive markers and target genes of ProLindac, a novel DACH-platinum compound, compared to oxaliplatin and cisplatin in human cancer cell lines" will be presented on Monday April 14 from 1:00pm to 5:00pm in the "Novel Targets and Mechanisms 2" session held in Exhibit Hall B-F.

ProLindac is Access' novel DACH platinum prodrug which has been shown to be active in a wide variety of solid tumors in both preclinical models and in human trials. Access believes that ProLindac's unique molecular design potentially could eliminate some of the toxic side effects seen in the currently marketed DACH platinum, Eloxatin(TM) or oxaliplatin, which has sales in excess of $2 billion.

"We are grateful for the work and data our European collaborators are presenting at this prestigious meeting next week," stated Jeffrey B. Davis, Access' President & CEO. "As we continue to collect clinical and preclinical data on ProLindac, we are increasingly encouraged and excited about the potential of ProLindac to become a very important tool in the fight against cancer. In the ongoing recurrent ovarian trial, ProLindac continues to show significant DACH platinum anti-cancer activity, with significant reductions in CA-125 biomarkers and anti-tumor activity. We are seeing responses which suggest that ProLindac could be more active as a monotherapy in this patient population than was previously reported for carboplatin and oxaliplatin. Importantly, the side effect profile continues to be quite benign in comparison to o
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New Legislation Would Expedite Medicare Patient Access to Physical Therapy
2. SurgiQuest Announces First Procedure Using AirSeal(TM) Access System
3. Medicare Advantage Plans Have New, Better Way to Access CMS Data
4. Stryker to Provide Webcast and Telephone Access to Annual Shareholder Meeting
5. Increasing access to antiretroviral drugs would drastically cut AIDS deaths in South Africa
6. Open Biosystems Open Access RNAi Program Continues to Gain Momentum Worldwide
7. Toms of Maine Helps Increase Access to Dental Care
8. Medicare Bidding Program for Durable Medical Equipment May Harm Small Businesses and Decrease Patient Access to Care, Say 137 Members of Congress
9. Cardinal Health, GE Healthcare Broaden Relationship to Offer Greater Access to Myoview(TM) Imaging Agent
10. Governor Rendell Says Pennsylvania is One Step Closer to Providing Access to Health Care for Pennsylvanias Uninsured
11. Country Music Star Troy Gentry Partners With National Non-Profit Patient Advocate Foundation to Spread the Message About Challenges to Healthcare Access for Insured and Uninsured Americans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Steven Reinberg HealthDay Reporter , ... add weight and length may be showing a genetic propensity ... adults, certain genes have been linked to increased body fat, ... fat and lean muscle, the researchers said. At 1 ... By ages 2 and 3, however, these genes were linked ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter ... of conventional in vitro fertilization (IVF) -- the incubation of ... in a device inside the vagina, new research suggests. ... device, called an INVOcell, might sharply cut costs for pricey ... technology more accessible to those who don,t live near big-city ...
(Date:10/20/2014)... The newly updated Worldwide Medical Market Forecasts to ... figures and forecasts on the global medical markets. , ... the Worldwide Medical Market Forecasts to 2019 ... the worldwide medical market to reveal key insights into ... for 2010-2019, covering each country market individually, allowing you ...
(Date:10/20/2014)... NY (PRWEB) October 20, 2014 ... non-profit organization that helps New Yorkers living with ... changes toward health, housing, recovery and self-sufficiency. Each ... transformed the local community through their tireless efforts. ... Marc Shapses , has been selected as ...
(Date:10/20/2014)... Zereana Jess-Huff, a 34-year-old mother, corporate executive and ovarian ... to think outside the bra. She doesn’t try to hide ... awareness about women’s other lady parts. , "We have won ... color pink and everybody knows what you’re talking about,” Jess-Huff ... has not been won when it comes to gynecologic cancers. ...
Breaking Medicine News(10 mins):Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3
... wee small hours Friday with an all-night music festival in ... streets , while New York swung along for the first ... from area to area. Thousands flocked to Abbesses on the ... small-time artists enjoyed their 15 minutes of fame, while locals ...
... Medical Association will decide later this month whether internet and ... will vote on the issue at the AMA national meeting ... disease is teens holing up in their rooms, ignoring friends, ... belligerence soars. ,Video games for certain kids can be ...
... trial of its kind in the world, 60 patients who ... with selected stem cells from their own bone marrow ... will test whether the stem cells will repair heart muscle ... formation and hence impaired heart contraction. ,Professor Jeremy ...
... Jade Goody is reportedly devastated after suffering a miscarriage of the ... 25-year-old, who was caught in a controversy after the Big Brother ... baby as it came as a surprise. ,Sadly for ... when the reality TV star miscarried. ,And though she ...
... to British Prime Minister Tony Blair, his wife Cherie has ... legislation that imposes ban on smoking from July 1 onwards. ... as to how the smoking ban may breach the human ... in St James's, Central London, which has bondage tables and ...
... new study has found that, apart from being heavy, overweight ... ,A study of 40 overweight children in Edmonton has revealed ... a structural protein found in intestinal cholesterol. ,The ... cholesterol levels, which are characteristically high in overweight adults, remained ...
Cached Medicine News:Health News:France Celebrates Summer With All-night Music Fest; NY Swings Along 2Health News:Video Game Addiction to Be Termed as a Medical Condition 2Health News:A New Milestone in Stem Cell Research 2Health News:Cherie Blair to Challenge Hubbys Smoking Ban on Human Rights Ground 2Health News:Researchers Identify New Risk Marker for Obese Children 2
(Date:10/22/2014)... , Oct. 22, 2014 WHEN: Wednesday, ... Online, complimentary registration available at: http://bit.ly/1yStiU9 ... Archana Vidyasekar and Visionary Innovation Research Group ... wireless electricity, self-assembling materials, nanobots and flexible ... which will transform our lives in the ...
(Date:10/22/2014)... NEW YORK , Oct. 22, 2014 ... and dermatology therapies. PV-10, its novel investigational drug for ... the potential for systemic side effects. Its oncology focus ... liver. Provectus has completed phase 2 trials of PV-10 ... as a topical treatment for atopic dermatitis and psoriasis. ...
(Date:10/22/2014)... Oct. 22, 2014  Recently published clinical studies of ... already substantial database of evidence. This data has led ... Stretta therapy for sufferers of refractory GERD. ... supporting Stretta therapy as a safe and effective ... Stretta therapy available to nearly 50 million Americans. The ...
Breaking Medicine Technology:Futuristic Technologies That Will Transform Our World Beyond 2030 2Futuristic Technologies That Will Transform Our World Beyond 2030 3Futuristic Technologies That Will Transform Our World Beyond 2030 4Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2Recent Clinical Study Data Confirms Efficacy of Stretta Therapy - Spurs Additional Insurance Coverage and Financing Round 2
... 28, 2011 Advanced Cell Diagnostics, Inc. (ACD) ... utilizing RNAscope™ technology to detect human papillomavirus (HPV) ... and neck cancer. HPV status determined by the ... outcome and highly concordant with that determined by ...
... Company increases 2011 financial guidance of revenues to a range of ... guidance of adjusted diluted EPS to a range of $4.20 to $4.30 ... range of $2.43 to $2.53 Total quarterly ... percent versus prior year; Reported quarterly ...
Cached Medicine Technology:ACD Announces Clinical Study Results Using its RNAscope™ Technology 2ACD Announces Clinical Study Results Using its RNAscope™ Technology 3Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results 2Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results 3Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results 4Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results 5Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results 6Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results 7Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results 8Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results 9Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results 10Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results 11Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results 12Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results 13Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results 14Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results 15
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
... Hamilton is precision, ergonomics, and value!, ... with soft non-slip, contoured handle , Finer ... spring action , Stress-free tip ejection with ... for easy decontamination and sterilization without the ...
... The Finnpipette Digital Multichannel, with ... lighter work of routine laboratory ... these advanced features: Soft-touch tip ... volume pipetting (0.5-10ul models), Entire ...
... Research pro Electronic Pipette is ideal for ... Its easy-to-follow display, ergonomically-placed operating buttons, and ... reverse pipetting and diluting make this a ... functions of a manual pipette without any ...
Medicine Products: